About Us       Microbiome       What We Do       Careers

RESOURCES  FROM  ARRANTA

LATEST MICROBIOME INDUSTRY NEWS

APRIL 2021

Fecal microbiota potentiate checkpoint inhibitors, unleash microbiome startups – Nature

Altered gut microbiome and autism like behavior are associated with parental high salt diet in male mice – Nature, Scientific Reports

The aging gut microbiome and its impact on host immunity – Nature, Genes & Immunity

Microbiota-based markers predictive of development of Clostridioides difficile infection – Nature Communications

Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis – Cell Reports Medicine

Regulation of splenic monocyte homeostasis and function by gut microbial products - Cell: iScience

ARCHIVE

Learn more about Arranta Bio and our commitment to microbiome innovators and the patients they serve by downloading our latest articles with interviews from our SMEs.

Read the latest press releases and news from Arranta Bio.

Reserve a copy of our upcoming white paper.

Videos, presentations, and interviews with our subject matter experts.

C O N T A C T

Get in Touch

We're always open to engaging with individuals interested in our company or the microbiome therapy market in general. 

We look forward to hearing from you.

Headquarters &
cGMP Manufacturing
650 Pleasant Street
Watertown, MA 02472

Process Development
& cGMP Manufacturing
1622 NW 55th Pl.
Gainesville, FL 32653

info@arrantabio.com

For CDMO Service Inquiries: bd@arrantabio.com